Home » Topics » BioWorld Science

BioWorld Science
RSS

MRX-1669, a novel small-molecule Myc inhibitor with promising in vitro activity

Nov. 12, 2019

SAR-20351 demonstrates promising safety and efficacy in syngeneic tumor models

Nov. 12, 2019

Turning Point Therapeutics initiates phase I/II trial of TPX-0046

Nov. 12, 2019

Topline phase II data presented for TNP-2092

Nov. 12, 2019

Indalo Therapeutics presents first clinical data for IDL-2965

Nov. 12, 2019

FDA clears IND application for ACH-5228

Nov. 12, 2019

Cerecor announces milestones in clinical development programs of CERC-301 and CERC-802

Nov. 12, 2019

Glutamine blockade: Bad for tumor cells, good for T cells

Nov. 12, 2019

Long, low growth factor signaling promotes healing

Nov. 12, 2019

LRG as a novel biomarker to monitor the efficacy of adalimumab treatment in UC and CD

Nov. 12, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...